ClinicalTrials.gov
public full text
Public Domain
IFN-beta 1b and Remdesivir for COVID19
A 5-day combination of interferon β-1b and remdesivir will expedite the recovery, suppress the viral load and shorten hospitalisation in patients with SARS-CoV-2 infection compare to the control arm
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study#802731
- University of Utah COVID-19 Hydrochloroquine Trial#911608
- Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection#1088024
- Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19#1074034
- Ivermectin Versus Standard Treatment in Mild COVID-19#845941
Record · ID 1096947
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive